Shai Mulinari

Search results

• 2024

  Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysis

  Larkin, J., Matthes, B., Azribi, M., Kearns, C., Mulinari, S., Rickard, E., Moriarty, F., Fahey, T. & Ozieranski, P., 2024 Nov, In: Health Policy. 149, November 2024, 105155.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Methodology 100%
  • Drug 100%
  • Payment 100%
  • Disclosure 66%
  • Healthcare 33%

• Aligning digital biomarker definitions in psychiatry with the National Institute of Mental Health Research Domain Criteria framework

  Mulinari, S., 2024 Oct 13, In: NPP—Digital Psychiatry and Neuroscience. 2, 15.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Mental Health 100%
  • Review Article 100%
  • Electronic Circuit 100%
  • Face 33%
  • Nomenclature 33%

• Broken beyond repair: self regulation of industry payments to clinicians and hospitals

  Ozieranski, P. & Mulinari, S., 2024 Jul 12, In: BMJ: British Medical Journal. 386, q1559.

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

  • Hospital 100%
  • Drug 100%
  • Clinician 100%
  • Payment 100%
  • Medical Device 100%

• Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals

  Hakariya, H., Moriarty, F., Ozaki, A., Mulinari, S., Saito, H. & Tanimoto, T., 2024 Jul 10, In: Clinical and Translational Science. 17, 7, e13879.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug 100%
  • Medicine 60%
  • Medical Device 60%
  • Authority 40%
  • Patient 20%

• Läkares jäv bör redovisas i media

  Marx, A., Mulinari, S. & Bremdal, P., 2024 Jul 3, Dagens Media.

  Research output: Contribution to specialist publication or newspaper › Newspaper article

• Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self-regulation within the European context

  Mulinari, S., Pashley, D. & Ozieranski, P., 2024 Jun 20, (E-pub ahead of print) In: Regulation and Governance.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Analysis 100%
  • UK 100%
  • Company 100%
  • Self-Regulation 100%
  • Complaint 100%

• Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval

  Hakariya, H., Ozaki, A., Mulinari, S., Moriarty, F. & Tanimoto, T., 2024 Jun 12, (E-pub ahead of print) In: QJM - Monthly Journal of the Association of Physicians.

  Research output: Contribution to journal › Letter › peer-review

• Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: An observational study

  Larkin, J., Mulinari, S., Ozieranski, P., Lynch, K., Fahey, T., Ozaki, A. & Moriarty, F., 2024 Apr 15, In: Health Policy and Technology. 13, 2, 100865.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Payment System 100%
  • Industry 100%
  • Healthcare Organization 100%
  • Payment 100%
  • Medical Device 100%

• Delays in dealing with complaints against drug companies are growing, BMJ finds

  Boytchev, H., Mulinari, S. & Ozieranski, P., 2024 Feb 14, BMJ (Clinical research ed.), 384, p. q365.

  Research output: Contribution to specialist publication or newspaper › Specialist publication article › Research

  Open Access

• Race in clinical trials in Sweden: how regulatory and medical standards in clinical research trump the post-racial discourse

  Mulinari, S. & Bredström, A., 2024, In: Sociology of Health & Illness. 46, 2, p. 315-332

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Research 100%
  • Sweden 100%
  • Standards 100%
  • Discourse 100%
  • Racial 100%
  96 Downloads (Pure)
• 2023

  Authors’ reply to Fell

  Mulinari, S. & Ozieranski, P., 2023 Nov 2, In: British Medical Journal. 383, p2493 .

  Research output: Contribution to journal › Letter

  • Healthcare Organization 100%
  • Regulatory System 100%
  • Roles 50%
  • Positive Development 50%
  • Encourage People 50%

• Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database

  Ozieranski, P., Saghy, E. & Mulinari, S., 2023 Nov 1, In: PLoS ONE. 18, 11, e0290022.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Trust 100%
  • Payment 100%
  • National Health Service 100%
  • Payment System 100%
  • Market Concentration 100%

• Unethical pharmaceutical marketing: a common problem requiring collective responsibility

  Mulinari, S. & Ozieranski, P., 2023 Sept 19, In: BMJ (Clinical research ed.). 382, e076173.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File
  118 Downloads (Pure)

• International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency

  Ozieranski, P., Saito, H., Rickard, E., Mulinari, S. & Ozaki, A., 2023 Mar 4, In: Globalization and Health. 19, 14, p. 1-42

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Regulation 100%
  • Payment System 100%
  • Pharmaceutical Industry 100%
  • Disclosure 100%
  • Self-Regulation 100%
  104 Downloads (Pure)

• Conceptual unclarity about COVID-19 ethnic disparities in Sweden: Implications for public health policy

  Bredström, A. & Mulinari, S., 2023 Mar 1, In: Health. 27, 2, p. 186-200

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Sweden 100%
  • Health Policy 100%
  • Public Health Policy 100%
  • COVID-19 100%
  • Ethnic Disparity 100%
  95 Downloads (Pure)

• Short-circuiting biology: Digital phenotypes, digital biomarkers, and shifting gazes in psychiatry

  Mulinari, S., 2023 Jan 12, In: Big Data and Society. 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Human Behavior 100%
  • Mental Health 100%
  • Epistemology 100%
  • Field Research 100%
  • Directing 100%
  51 Downloads (Pure)
• 2022

  “Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation

  Mulinari, S. & Bredström, A., 2022 Dec 14, In: BioSocieties.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmaceuticals Regulation 100%
  • Medicine 33%
  • Drug 33%
  92 Downloads (Pure)

• De unga gör helt rätt när de stämmer staten

  Translated title of the contribution: The youth are completely right when suing the stateMoberg, C., Corvellec, H., Lindroth, A., Isacson, M., Nilsson, L., Nicholas, K., Björck, S., Lee, J., Gerle, E., Caretta, M. A., Galafassi, D., Hornborg, A., Ullström, S., Olsson, L., Jerneck, A., Koch, M., Roldin, P., Sunesson, S., Kritzberg, E. & Hammarlund, D. & 186 others, Wamsler, C., Krause, T., Tyler, T., Malmqvist, E., Osberg, G., Reindl, K., Lefstad, L., Björnerås, C., De Rosa, S. P., Koglin, T., Bjermo, T., Isaxon, C., Isgren, E., Richter, J. L., Johansson, E., Jarenmark, M., Friberg, J., Wårlind, D., Jack, T., Holmberg, K., Bergman Rosamond, A., Vogl, V., Olofsson, J., Magalhaes Teixeira, B., Palm, E., Algers, J., Gjerløv Fiig, N. A., Ramasar, V., Lopez de Lapuente Portilla, A., Khan, J., Palm, J., Haraldsson, J., Barmark, M., Stroh, E., Filipsson, H. L., Sernhed, K., Wengelin, M., Bauer, F., Persson, T., Brandstedt, E., Mccormick, K., Carton, W., Stattin, S., Gren, N., Nikoleris, A., Wickenberg, P., Garson, K., Zackari, K., Droste, N., Gunnemyr, M., Hansson, L.-A., Lantz, E., Sternudd, C., Ekström, H., Jonsson, A., Dahlner, A., Sörgärde, N., Alcer, D., Rennstam, J., Gabrielsson, S., Ottosson, M., Eklundh, L., Andersson, M., Schwarz, J., Tilsted, J. P., Kiss, B., Halldenius, L., Knaggård, Å., Persson, A., Kolte, O., Lindh, L., Chertkovskaya, E., Hultman, M., Thånell, K., Manners, I., Kristensson, A., Nieradzik, L., Lundberg, A., Cronberg, N., Rydhe, E., Klemmensen, R., Herlitz, A., Perrey, H., Pugh, R., Björkdahl, A., Lundberg, T., Mårsell, E., Samper, J. A., Sandström, I., Ståhl, L.-H., Prentice, H. C., Carlson, S., Andréasson, P.-G., Liljas, A., Zalar, A., Fridlund, P., Sporre, M., Löndahl, J., Björling, F., Kalm, S., Barinaga, E., Mulinari, S., Mulinari, D., Lindqvist, A., Vestberg, S., Claréus, B., Boije af Gennäs Erre, E., Viborg, G., Nilsson, K., Tagesson, A., Brogaard, S., Davidson, P., Harrie, L., Elvén Eriksson, H., Hickmann, T., Fauré, E., Wullenkord, M., Giertz, A., Germundsson, T., Nilsson, F. L., Montesino, N., Sjöström, C., Pettersson, G., Alkan Olsson, J., Cardeña, E., Mottaghi, M., Sundkvist, E., Tellhed, U., Mundaca, L., Lindström, L., Sörensen, J., Mobini, S., Hederström, V., Becker, P., Klysing, A., Mattisson, K., Svensson, J., Svenbro, M., Hanson, H., Oudin, A., Flanagan, E., Takman, M., Ritthammer, S., Månefjord, J., Sonander, A., Nafstad, I., Sjöström, P., Dietler, D., Hassel, H., Käll, J., Akselsson, R., Bohgard, M., Ingvarson, J., Steen, K., Cedergren, A., Nordbeck, P., Davidsson, S., Angelöw, A., Ahrné, S., Lantto, R., Psouni, E., Nicoson, C., Jeppsson, B., Côte, M., Alvesson, M., Leo Sandberg, E., Möllergren, G., Karlsson, D., Bäckman, J., Angelopulos Baroutsis, N., Alenius Wallin, L., Lundell, E., Stedt, J., Forsberg, K., Gnewski, M., Larsson, M., Grillitsch, M., Takedomi Karlsson, M., Månefjord, H., Giese, L., Betsholtz, A., Wrisberg, A., Söderlind, M., Vilhelmsson, A., Stedt, K. & et al., 2022 Dec 7, Aftonbladet.

  Research output: Contribution to specialist publication or newspaper › Newspaper article

  Open Access

• The making of a Swedish strategy: How organizational culture shaped the Public Health Agency's pandemic response

  Olofsson, T., Mulinari, S., Hedlund, M., Knaggård, Å. & Vilhelmsson, A., 2022 Dec, In: SSM Qualitative Research in Health. 2, 100082.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Swedish 100%
  • Health Policy 100%
  • Culture of Work 100%
  • Organizations 75%
  • Approach 50%

• Content and strength of conflict of interest policies at Scandinavian Medical Schools: a cross sectional study

  Fabbri, A., Mulinari, S., Johansson, M., Ghaur, W., Khalil, A. M. & Lundh, A., 2022 Nov 27, In: BMC Medical Education. 22, 812.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Policy 100%
  • Schools 100%
  • Cross-Sectional Study 100%
  • Conflict of Interest 100%
  • Interaction 13%
  53 Downloads (Pure)

• Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark

  Mulinari, S., Pashley, D. & Ozieranski, P., 2022 Nov 8, In: Health Policy. 126, 12, p. 1256-1262

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Patient 100%
  • Patient Advocacy 100%
  • Disease 30%
  • Payment 20%
  • Breast Cancer 10%
  77 Downloads (Pure)

• Capitalizing on transparency: commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act

  Mulinari, S. & Ozieranski, P., 2022 Feb 9, In: Big Data and Society. 9, 1

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Marketing 100%
  • Drugs 100%
  • Physician 100%
  • Surveillance 100%
  • Influence 50%

• A “patient-industry complex”? Investigating the financial dependency of UK patient organisations on drug company funding

  Ozieranski, P., Janos, P., Rickard, E., Mulinari, S. & Csanadi, M., 2022 Jan 23, In: Sociology of Health & Illness. 44, 1, p. 188-210

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Organizations 100%
  • UK 100%
  • Patients 100%
  • Company 100%
  • Funding 100%
  78 Downloads (Pure)

• Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?

  Pashley, D., Ozieranski, P. & Mulinari, S., 2022, In: International Journal of Health Services. 52, 3, p. 347-362

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Regulation 100%
  • Industry 100%
  • Pharmaceutical Industry 100%
  • Disclosure 100%
  • Self-Regulation 100%
  100 Downloads (Pure)

• Tip of the iceberg? Country- and company-level analysis of drug company payments for research and development in Europe

  Ozieranski, P., Martinon, L., Jachiet, P.-A. & Mulinari, S., 2022, In: International Journal of Health Policy and Management. 11, 12, p. 2842-2859

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Analysis 100%
  • Europe 100%
  • Company 100%
  • Research and Development 100%
  • Drugs 100%
• 2021

  Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: A European policy review

  Ozieranski, P., Martinon, L., Jachiet, P.-A. & Mulinari, S., 2021 Dec 16, In: BMJ Open. 11, e053138.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Enterprise 100%
  • Payment System 100%
  • Europeans 100%
  • Professionals 100%
  • Organizations 100%
  82 Downloads (Pure)

• Drug company payments to General Practices in England: cross-sectional and social network analysis

  Saghy, E., Mulinari, S. & Ozieranski, P., 2021 Dec 7, In: PLoS ONE. 16, 12, e0261077.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • UK 100%
  • Company 100%
  • Social Network Analysis 100%
  • Drugs 100%
  • Healthcare Organization 100%
  102 Downloads (Pure)

• Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries

  Mulinari, S., Martinon, L., Jachiet, P.-A. & Ozieranski, P., 2021 Jul 1, In: Health Policy. 125, 7, p. 915-922 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • European Country 100%
  • Level Analysis 100%
  • Health Care 100%
  • Europeans 100%
  • Professionals 100%

• Is there evidence for the racialization of pharmaceutical regulation? Systematic comparison of new drugs approved over five years in the USA and the EU

  Mulinari, S., Vilhelmsson, A., Ozieranski, P. & Bredström, A., 2021 Jul, In: Social Science and Medicine. 280, 114049.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmaceuticals Regulation 100%
  • Hydralazine Plus Isosorbide Dinitrate 50%
  • Pharmaceutical Medicine 33%
  95 Downloads (Pure)

• Data Transparency and Pharmaceutical Regulation in Europe: Road to Damascus, or Room without a View?

  Davis, C., Mulinari, S. & Jefferson , T., 2021 Jun 17, Transparency, Power, and Influence in the Pharmaceutical Industry : Policy Gain or Confidence Game?. Fierlbeck, K., Graham, J. & Herder, M. (eds.). University of Toronto Press, p. 63-94

  Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

• Sociologisk forskning om covid-19-pandemin: En introduktion

  Translated title of the contribution: Sociological research on the Covid-19 pandemic: an introductionMulinari, S., Soneryd, L. & Öhman, S., 2021 Jun 7, In: Sociologisk Forskning. 58, 1-2, p. 5-15

  Research output: Contribution to journal › Debate/Note/Editorial

  Open Access

  • Situation 100%
  • Introduction 100%
  • Sweden 50%
  • Uncertainty 50%
  • Routine 50%

• Failure of responsive regulation? Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe

  Mulinari, S., Davis, C. & Ozieranski, P., 2021 May 6, In: Journal of White Collar and Corporate Crime. 2, 2, p. 69-80

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Europe 100%
  • Legislation 100%
  • Company 100%
  • Failure 100%
  • Marketing 100%
  154 Downloads (Pure)

• Sweden

  Olofsson, T., Vilhelmsson, A., Hedlund, M., Knaggård, Å. & Mulinari, S., 2021 Jan 12, Comparative Covid Response: Crisis, Knowledge, Politics. Jasanoff, S., Hilgartner, S., Hurlbut, J. B., Özgöde, O. & Rayzberg, M. (eds.). 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter in Report › Research

  Open Access

  • Case Study 100%
  • Sweden 100%
  • Management 100%
  • Health Economics 100%
  • Health 100%
• 2020

  Pharmaceutical lobbying and pandemic stockpiling: A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand COVID-19

  Vilhelmsson, A. & Mulinari, S., 2020 Oct 8, In: Acta Sociologica. 63, 4, p. 439-442

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • COVID-19 100%
  • Antivirus Agent 100%
  • SARS Coronavirus 50%
  • Severe Acute Respiratory Syndrome Coronavirus 2 33%
  • Influenza 33%

• Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)

  Ozieranski, P., Csanadi, M., Rickard, E. & Mulinari, S., 2020 Sept 20, In: BMJ Open. 10, 9, p. 1-11 10:e037351.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Patient 100%
  • Donor 100%
  • Payment 100%
  • Payment System 100%
  • Pharmaceutical Industry 100%

• Five years of pharmaceutical industry funding of patient organisations in Sweden: cross-sectional study of companies, patient organisations and drugs

  Mulinari, S., Vilhelmsson, A. J., Rickard, E. & Ozieranski, P., 2020 Jun 24, In: PLoS ONE. e.0235021.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Patient 100%
  • Drug 100%
  • Cross Sectional Study 100%
  • Payment 46%
  • Disease 30%

• Sociologiska perspektiv på coronakrisen: Fyra sociologer om samhällets reaktion på covid-19

  Danielsson, E., Liljeros, F., Mulinari, S. & Soneryd, L., 2020 Apr 8, In: Sociologisk Forskning. 57, 1, p. 67-76

  Research output: Contribution to journal › Letter

  Open Access

  File
  493 Downloads (Pure)

• Revisiting the pharmaceuticalisation of pandemic influenza using Lukes’ framework of power

  Mulinari, S. & Vilhelmsson, A., 2020 Feb 12, In: Sociology of Health & Illness. 42, 2, p. 327-341

  Research output: Contribution to journal › Article › peer-review

  • Vaccination 100%
  • Mass Immunization 100%
  • Pandemic Influenza 100%
  • Decision Making 100%
  • Social Actor 100%

• The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza

  Mulinari, S. & Davis, C., 2020 Jan 24, In: Social Studies of Science. 50, 1, p. 145-169 25 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Bias 100%
  • Public Health 100%
  • Reading 100%
  • Health Concern 100%
  • Scientific Theory 100%
  135 Downloads (Pure)

• Bengt Olle Bengtsson intervjuad av Shai Mulinari: Om genetisk likhet och skillnad

  Bengtsson, B. O. & Mulinari, S., 2020, Fronesis, 66-67, p. 24-38.

  Research output: Contribution to specialist publication or newspaper › Specialist publication article › Popular science

• Ras i genetikens tidevarv

  Barot, S., Bredström, A., Mulinari, S. & Shutzberg, M., 2020, Fronesis, 66-67, p. 8-17 9 p.

  Research output: Contribution to specialist publication or newspaper › Specialist publication article › Popular science

  Open Access

• Ras och genetiska skillnader: Introduktion till avsnittets texter

  Mulinari, S., 2020, Fronesis, 66-67, p. 20-23 4 p.

  Research output: Contribution to specialist publication or newspaper › Specialist publication article › Popular science

• Svenska gener? Om stratifierad precisionsmedicin och genetikens etniska gränsdragningar

  Bredström, A. & Mulinari, S., 2020, Fronesis, 66-67, p. 65-81.

  Research output: Contribution to specialist publication or newspaper › Specialist publication article › Popular science
• 2019

  The whistleblowing drama behind Astellas’s suspension from the ABPI

  Cohen, D., Mulinari, S. & Ozieranski, P., 2019 Jul 2, In: BMJ: British Medical Journal. 366, 1453.

  Research output: Contribution to journal › Letter

  • Time 100%
  • Company 100%
  • Employees 100%
  • Japanese 100%
  • Drugs 100%

• Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

  Ozieranski, P., Csanadi, M., Rickard, E., Tchilingirian, J. & Mulinari, S., 2019 Jun 21, In: JAMA Network Open. 2, 6, p. e196253

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Payment System 100%
  • Pharmaceutical Industry 100%
  • Health Care 100%
  • Payment 100%
  • Health Care Organization 100%
  115 Downloads (Pure)

• Exposing drug industry funding of UK patient organisations

  Ozieranski, P., Richard, E. & Mulinari, S., 2019 May 23, In: BMJ: British Medical Journal. 365, l1806 .

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Patient 100%
  • Drug 100%
  • Interpersonal Communication 100%
  • Payment 50%
  171 Downloads (Pure)

• Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

  Richard, E., Ozieranski, P. & Mulinari, S., 2019, In: Health Policy. 123, 12, p. 1244-1250

  Research output: Contribution to journal › Article › peer-review

  • Patient 100%
  • Payment 100%
  • Indicator 10%
• 2018

  Explaining biological depression theories

  Mulinari, S., 2018 Dec 6, In: Philosophy, Psychiatry, and Psychology. 4, 25, p. 309-310 2 p.

  Research output: Contribution to journal › Letter

  • Theory 100%
  • Depression 100%
  • Evolution 100%
  • Research 33%
  • Approach 33%

• Let the drugs lead the way! On the unfolding of a research programme in psychiatry

  Mulinari, S., 2018 Dec 6, In: Philosophy, Psychiatry, and Psychology. 4, 25, p. 289-302 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Psychiatry 100%
  • Psychoactive Drug 50%
  • Psychotropic Agent 50%
  • Brain 25%
  • Neuroplasticity 25%

• Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny

  Mulinari, S. & Davis, C., 2018 Nov 15, In: Health Research Policy and Systems. 2018, 16, p. 98 2 p.

  Research output: Contribution to journal › Letter

  Open Access

  File

  • Evaluation 100%
  • Public Scrutiny 100%
  • Public Health 100%
  • Workforce 100%
  • Scientist 100%
  173 Downloads (Pure)